InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-8.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Yang Rick, Executive. Officer active across 4 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 5 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1.8m. History available since 17 July 2023. The latest transaction was filed on 22 April 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
1,023,103 sharesCommon StockSEC:0000950170-24-107542:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047680:0
Ideal exit: 17 Jan 2025 (T+270)
333,333 shares@ US$3.00100.0% of flowCommon StockSEC:0001209191-23-042805:0
Ideal exit: 12 Apr 2024 (T+270)
2,715,968 sharesCommon StockSEC:0001209191-21-044051
2,715,968 sharesCommon StockSEC:0001209191-21-044051:0
5 of 5 declarations
About Yang Rick
Rick Yang is a key member of Monte Rosa Therapeutics, Inc. Although his specific role is not detailed, he contributes to the strategic direction of the company, which focuses on developing innovative therapies. Rick brings valuable expertise in the biopharmaceutical field, helping Monte Rosa advance its mission to transform healthcare. His commitment to innovation and operational excellence is essential for the company's success.
